UK markets open in 2 hours 26 minutes

NVO Jan 2025 180.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
40.300.00 (0.00%)
As of 02:24PM EST. Market open.
Full screen
Previous close40.30
Open41.00
Bid0.00
Ask0.00
Strike180.00
Expiry date2025-01-17
Day's range40.30 - 41.00
Contract rangeN/A
Volume19
Open interest87
  • Reuters

    UPDATE 1-Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon

    Eleven people suffered bouts of dangerously low blood sugar in Lebanon this year, one of whom required hospitalization, after injecting suspected fake versions of Novo Nordisk's diabetes drug Ozempic, according Lebanese health officials. A director for the Lebanese Ministry of Public Health, Rita Karam, said officials suspected the drugs were fake after discovering the doses were different from the ones calibrated for authentic Ozempic injector pens.

  • Reuters

    Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon

    Eleven people suffered bouts of dangerously low blood sugar in Lebanon this year, one of whom required hospitalization, after injecting suspected fake versions of Novo Nordisk's diabetes drug Ozempic, according Lebanese health officials. A director for the Lebanese Ministry of Public Health, Rita Karam, said officials suspected the drugs were fake after discovering the doses were different from the ones calibrated for authentic Ozempic injector pens. Explosive demand for Ozempic and other drugs used for weight loss, including Eli Lilly's Mounjaro and Novo's Wegovy, is fueling a global surge in counterfeit versions, Reuters interviews with law enforcement, anti-counterfeiting and public health officials showed last month.

  • Zacks

    AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag

    The FDA grants breakthrough therapy designation to AbbVie's (ABBV) Epkinly in follicular lymphoma indication. The EMA validates a regulatory filing seeking label expansion for the drug.